Sample size calculation for R-SABE [RSABE / ABEL]

posted by Lucas – Brazil, 2014-02-07 12:41 (3729 d 17:11 ago) – Posting: # 12362
Views: 17,162

Hi everybody.

ANVISA (Brazil's regulatory agency) is now studying the possibility of accepting EMA's method for scaling the BE acceptance interval based on the variability of the reference medication. So we are struggling a little bit in the sample size calculation, since it is very new to us. We have always used PASS for sample size calculation, for the standard BE studies, and did not manage to reproduce the results of PowerTOST calculations for RSABE. Is a whole different calculus? For example, when I try to calculate a sample size for a full replicate crossover design (TRTR, RTRT) considering a true ratio of 0.95, a target power of 80% and a reference ISCV of 63%, in PASS I got 28 subjects (considering the equivalence limits of 69.84%–143.19%) and in PowerTOST I got 22 subjects.
Can you guys help me with that? Should I throw away my PASS? :confused:


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
124 visitors (1 registered, 123 guests [including 4 identified bots]).
Forum time: 06:52 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5